Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.45), $0.01 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.56 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.